Complications associated with peripherally inserted central catheters and Hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids-Reference-Cited by-同舟云学术

Complications associated with peripherally inserted central catheters and Hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids

Published:2021-11 Issue: Volume:189 Page:106649
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Hinojosa Williams,Cruz Alba,Cruz-Utrilla Alejandro,Cristo Ropero María José,López-Medrano Francisco,Gómez Itziar,Arribas-Ynsaurriaga Fernando,Escribano-Subias Pilar

Funder

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference35 articles.

1. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group;Barst;N. Engl. J. Med.,1996

2. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension;Cabrol;J. Heart Lung Transplant.,2007

3. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension;Mizoguchi;Circ Cardiovasc Interv,2012

4. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Observational study in a referral unit;Velazquez;Rev. Esp. Cardiol.,2019

5. Survival in primary pulmonary hypertension the impact of epoprostenol therapy;McLaughlin;Circulation,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Predictive Modeling for PICC Line Complications in Oncology: A Retrospective Study;British Journal of Hospital Medicine;2024-09-09

2. Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a retrospective, observational study;Translational Cancer Research;2023-12